SPONSOR

University Hospital, Bordeaux

Total Trials

Recruiting

Phases

N/A

Conditions studied: Systemic Lupus Erythematosus Ventilatory Performances of Athletes During the Use of the Intra-oral Protections Mild Autonomous Cortisol Secretion Adenoma Non Secreting Adenoma Esophageal Cancer Surgery Indication Malnourished Neoadjuvant Treatment Benign Prostatic Hyperplasia Anxiety

University Hospital, Bordeaux is a clinical research sponsor with 15 registered studies on ClinicalTrials.gov, of which 15 are actively recruiting participants. Research covers conditions including Systemic Lupus Erythematosus, Ventilatory Performances of Athletes During the Use of the Intra-oral Protections, Mild Autonomous Cortisol Secretion Adenoma, Non Secreting Adenoma.

Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — University Hospital, Bordeaux

How many clinical trials has University Hospital, Bordeaux sponsored?

ClinicalMetric currently tracks 15 clinical trials sponsored by University Hospital, Bordeaux, of which 15 are actively recruiting participants. These trials cover conditions including Systemic Lupus Erythematosus, Ventilatory Performances of Athletes During the Use of the Intra-oral Protections, Mild Autonomous Cortisol Secretion Adenoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does University Hospital, Bordeaux research focus on?

University Hospital, Bordeaux clinical trials span Systemic Lupus Erythematosus, Ventilatory Performances of Athletes During the Use of the Intra-oral Protections, Mild Autonomous Cortisol Secretion Adenoma, Non Secreting Adenoma, Esophageal Cancer, and additional conditions. Sponsor focus areas evolve as trials complete and new programs launch.

How do I participate in a University Hospital, Bordeaux clinical trial?

To participate in a University Hospital, Bordeaux trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University Hospital, Bordeaux trials with current recruitment status updated daily.

University Hospital, Bordeaux

Frequently Asked Questions — University Hospital, Bordeaux

Clinical Trials by University Hospital, Bordeaux

Ferroptosis Role in the Pathophysiology of Systemic Lupus Erythematosus

Validation of a Digitalised Intraoral Protection

Ultradian Steroid Rhythms in Adrenal Incidentalomas

Evaluation of the Administration of Artificial Nutrition by Feeding Jejunostomy During Neoadjuvant Treatment on Postoperative Morbidity in the Context of Esophageal or Stomach Cancer

Comparison of Functional Outcomes of Ejaculation-preserving Partial Trans Urethral Resection of the Prostate With Complete Trans Urethral Resection of the Prostate for Benign Prostatic Obstruction

Contribution of Hypnosis on Image Quality in Cardiac MRI

Insulin Resistance in Multiple System Atrophy

Therapeutic Abstention and Surveillance of Intra-epithelial Histological Lesions of High Grade Cervical CIN2 (Cervical Intraepithelial Neoplasia Grade 2). SUIVICIN

Antenatal Investigation of Fetuses With Complex Congenital Heart Defects Using multiOMICS

Prospective Cohort Study of Neurogenetic Diseases

Study of Metabolic, Transcriptomic and Proteomic Characteristics in Relapsed Glioblastoma

Immunothrombosis With Septic Shock Undergoing Renal Replacement Therapy With the OXIRIS Membrane

ElectroPhySiological Characterization Of the Arrhythmia Substrate for Sudden Cardiac Death PrEdiction

Optimisation Strategy for Emergency Tracheal Intubation

Radiofrequency Endometrial Ablation or Uterine Artery Embolization for Treatment of Adenomyosis-related Abnormal Uterine Bleeding